{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-012325","form_type":"8-K","ticker":"MBRX","cik":"0001659617","company_name":"Moleculin Biotech, Inc.","filed_at":"2026-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.686054+00:00","generated_at":"2026-05-15T06:07:27.414125+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Shareholders approve issuance of up to 6.4M warrant shares; name change rejected","bullets":["Shareholders approved issuance of up to 6,367,956 shares upon exercise of warrants issued Feb 20, 2026.","Name change to Moleculin Inc. failed; received 2,015,174 'For' votes but needed majority of 4,933,110 outstanding shares.","Adjournment proposal passed to allow further proxy solicitation if needed.","A total of 2,382,989 shares were present at the Special Meeting, constituting a quorum."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-012325","json":"https://secwatch.observer/filing/0001437749-26-012325.json","markdown":"https://secwatch.observer/filing/0001437749-26-012325.md","text":"https://secwatch.observer/filing/0001437749-26-012325.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926012325/0001437749-26-012325-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926012325/mbrx20260408_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:07:27.414125+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}